Login to Your Account



Pharma: Clinic Roundup


Monday, September 9, 2013

• D&A Pharma, of Paris, will participate in the 14th Congress of the European Society for Biomedical Research on Alcoholism (ESBRA) in Warsaw Sept. 8-11, with results of trials of Alcover (sodium oxybate) showing that the drug met therapeutic objectives for management of alcohol dependence.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription